Public Employees Retirement System Of Ohio 2seventy Bio, Inc. Transaction History

Public Employees Retirement System Of Ohio

$22.6 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.6 - $5.79 $5,623 - $9,043	-1,562 Reduced 5.71%	25,808 $99,000
Q1 2024 May 15, 2024	BUY	$3.09 - $6.0 $81,483 - $158,220	26,370 Added 2637.0%	27,370 $146,000
Q4 2023 Feb 15, 2024	SELL	$1.57 - $4.58 $131,498 - $383,607	-83,757 Reduced 98.82%	1,000 $4,000
Q3 2023 Dec 19, 2023	BUY	$3.14 - $11.2 $140,970 - $502,823	44,895 Added 112.63%	84,757 $332,000
Q3 2023 Nov 15, 2023	BUY	$3.14 - $11.2 $140,970 - $502,823	44,895 Added 112.63%	84,757 $332,000
Q2 2023 Dec 19, 2023	BUY	$8.45 - $12.48 $37,602 - $55,536	4,450 Added 12.57%	39,862 $403,000
Q2 2023 Aug 15, 2023	BUY	$8.45 - $12.48 $37,602 - $55,536	4,450 Added 12.57%	39,862 $403,000
Q4 2022 Dec 19, 2023	SELL	$8.57 - $17.0 $422,886 - $838,865	-49,345 Reduced 58.22%	35,412 $331,000
Q4 2022 Feb 15, 2023	SELL	$8.57 - $17.0 $68,885 - $136,646	-8,038 Reduced 18.5%	35,412 $332,000
Q3 2022 Nov 15, 2022	BUY	$12.56 - $17.54 $545,732 - $762,113	43,450 New	43,450 $632,000

Others Institutions Holding TSVT

# of Institutions

126

Shares Held

45.6M

Call Options Held

122K

Put Options Held

19.8K

Kynam Capital Management, LP Princeton, NJ

5.95M
Shares

$18.5 Million
2.31% of portfolio
Goldman Sachs Group Inc New York, NY

4.22M
Shares

$13.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.77M
Shares

$11.7 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.66M
Shares

$11.4 Million
0.0% of portfolio
Morgan Stanley New York, NY

2.89M
Shares

$8.99 Million
0.0% of portfolio

View Full List

About 2seventy bio, Inc.

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $118M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

More about TSVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Account